发明名称 ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
摘要 Antibodies that specifically bind to CD38, as well as constructs comprising such antibodies fused to attenuated interferon alpha-2B proteins are provided. Anti-CD38-attenuated interferon alpha-2b fusion constructs may be used to inhibit proliferation in cancerous cells that express both CD38 and the receptor for IFN-alpha2b, as well as to induce apoptosis in such cells. Inhibition of proliferation and induction of apoptosis in cancerous cells may serve as the basis for the treatment of the underlying cancer.
申请公布号 SG11201508923V(A) 申请公布日期 2015.11.27
申请号 SG11201508923V 申请日期 2013.04.29
申请人 TEVA PHARMACEUTICALS AUSTRALIA PTY LTD. 发明人 CLARKE, ADAM;POLLARD, MATTHEW;DOYLE, ANTHONY, GERARD;BEHRENS, COLLETTE;YAMAGISHI, TETSUO;WILSON, DAVID, S. JR.;POGUE, SARAH, L.;TAURA, TETSUYA
分类号 C07K16/28;C07K14/00 主分类号 C07K16/28
代理机构 代理人
主权项
地址